Get startedLog in
    Picture of Percheron Therapeutics logo

    PER — Percheron Therapeutics News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    All News

    Brief: Antisense Therapeutics Gets Mhra Approval To Conduct Phase IIb Trial In UK For Atl1102

    Picture of Percheron Therapeutics logoPercheron Therapeutics
    27/06/2023 07:12
    June 27 (Reuters) - Antisense Therapeutics Ltd  ANP.AX :
    * MHRA APPROVAL RECEIVED TO CONDUCT PHASE IIB TRIAL IN UK
FOR
ATL1102 IN DMD

Source text for Eikon:  ID:nASX4GBHCR 
Further company coverage:  ANP.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Percheron Therapeutics

    See all news